6,8-Bis(benzylthio)octanoic acid
Axon 2125
CAS [95809-78-2]
MF C22H28O2S2MW 388.59
- Purity:100%
- Soluble in 0.1N NaOH(aq) and DMSO
Description
A small molecular inhibitor of a mitochondrial enzyme pyruvate dehydrogenase (PDH) complex; 6,8-bis(benzylthio)octanoic acid selectively attacks the regulatory aspects of tumor cell mitochondrial metabolism, activating both apoptotic (programmed cell death) and non-apoptotic (necrosis-like) cell death pathways.
KEYWORDS: 6,8-Bis(benzylthio)octanoic acid | PDH inhibitor | CAS [95809-78-2] | Pyruvate | PDH | Inhibitor | Enzymes
| Z Zachar et al. Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo. J. Mol. Med. (Berl). 2011, 89(11), 1137-1148. |
| KC Lee et al. Formation and anti-tumor activity of uncommon in vitro and in vivo metabolites of CPI-613, a novel anti-tumor compound that selectively alters tumor energy metabolism. Drug Metab. Lett. 2011, 5(3), 163-182. |
- Certificate of Analysis
- Material Safety Data Sheet
Chemical name
6,8-Bis(benzylthio)octanoic acid
Parent CAS No.
[95809-78-2]
Axon Medchem的业务之一，是独有的Axon Ligands配体库，在世界范围内，被认为是药物研发的标准。这其中，针对850余种生物靶标（包括细胞信号、基因转录、凋亡、细胞周期调控、CNS等），Axon Medchem拥有多达2000余种小分子抑制剂或调节剂。除了配体库，Axon Medchem还是欧洲著名的CRO公司，主要针对生物活性分子和药物类似分子展开合成及协议开发工作，在过去的10年中，Axon Medchem已经发现了多种潜在药物分子，并在生物医药界享有一定的声誉。
暂无问答
本网站将在规定时间内给予删除等相关处理。
